Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06639698
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-11
Brief Title:
Treatment of Women with PCOS of Phenotype D
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment of Menstrual Cycle Alterations in Women with PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin Vitamin D and Alpha-lactalbumin
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PT-PHD
Brief Summary:
In this study female patients diagnosed with PCOS of phenotype D will be enrolled They generally display the following characteristics menstrual cycle alterations polycystic ovary morphology at ultrasound normal blood levels of androgen particularly testosterone no signs of clinical hyperandrogenism
Current treatments for this condition include insulin sensitizers such as metformin and hormonal contraceptives However this specific phenotype of PCOS do not feature metabolic or hormonal alterations and the efficacy of these treatments has lately been questioned
In the present clinical trial patients will be given a dietary supplement containing Dioscorea extract source of Diosgenin a natural analog of progesterone vitamin D and alpha-lactalbumin for six month Restoration of regular menstrual cycle and physiological ultrasound appearance of the ovaries will be the primary goal of the intervention
Current treatments for this condition include insulin sensitizers such as metformin and hormonal contraceptives However this specific phenotype of PCOS do not feature metabolic or hormonal alterations and the efficacy of these treatments has lately been questioned
In the present clinical trial patients will be given a dietary supplement containing Dioscorea extract source of Diosgenin a natural analog of progesterone vitamin D and alpha-lactalbumin for six month Restoration of regular menstrual cycle and physiological ultrasound appearance of the ovaries will be the primary goal of the intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None